Chester County News and Community Website
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) revealed promising new findings on its atrioventricular interval modulation (AVIM) therapy during a late-breaking presentation at the Technology and Heart Failure …
Orchestra BioMed Unveils Groundbreaking Data on AVIM Therapy’s Potential to Prevent Heart Failure Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced the appointment of Christopher Cleary as an independent member of its Board of Directors, effective January 30, 2025. A …
Orchestra BioMed Welcomes Christopher Cleary to Board of Directors Read MoreNEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) this week announced its third quarter financial results for 2024, alongside significant updates on its clinical programs. The company is …
Orchestra BioMed Reports Q3 2024 Results, Advances Key Clinical Programs Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) recently reported its financial results for the second quarter ended June 30, 2024, alongside significant business developments. The company is …
Orchestra BioMed Holdings Reports Second Quarter 2024 Financial Results and Business Updates Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has added John Mack to its Board of Directors, effective from July 29, 2024. Mack brings over 30 years of …
Orchestra BioMed Appoints John Mack to Board of Directors Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) will host an in-person R&D day at the Lotte New York Palace Hotel on Tuesday, June 11, 2024, at 10:00 …
Orchestra BioMed to Showcase Breakthrough Hypertension Therapy at R&D Day Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) recently disclosed their financial results for the first quarter of 2024, while also providing an update on their business operations. …
Orchestra BioMed Unveils Q1 2024 Financial Results, Advances Pivotal Studies on Innovative Medical Therapies Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced a significant expansion of its global patent portfolio, signaling a major stride in the development of atrioventricular interval …
Orchestra BioMed Expands Global Patent Portfolio for Hypertension Therapy Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) is set to host an exclusive R&D day at the Lotte New York Palace Hotel on June 11, 2024, at …
Orchestra BioMed to Showcase AVIM Therapy at Upcoming R&D Event in New York Read More